Company: CRNX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000950170-25-029050
Chunk: 91

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-02-27
Form: 10-K
Item: Item 14
Chunk 91
---

     
    10-K

    2/28/2024

    97

    101.INS
     
    INLINE XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags

    X

    101.SCH
     
    INLINE XBRL Taxonomy Extension Schema Document

    X

    101.CAL
     
    INLINE XBRL Taxonomy Extension Calculation Linkbase Document

    X

F-32

    101.DEF
     
    INLINE XBRL Taxonomy Extension Definition Linkbase Document

    X

    101.LAB
     
    INLINE XBRL Taxonomy Extension Label Linkbase Document

    X

    101.PRE
     
    INLINE XBRL Taxonomy Extension Presentation Linkbase Document

    X

    104
     
    Cover Page Interactive Data File (embedded within the Inline XBRL document)

    X

† Portions of this exhibit have been omitted in compliance with Regulation S-K Item 601(b)(10)(iv).

# Indicates management contract or compensatory plan. 

* These certifications are being furnished solely to accompany this annual report pursuant to 18 U.S.C. Section 1350 and are not being filed for purposes of Section 18 of the Securities Exchange Act of 1934 and are not to be incorporated by reference into any filing of the Registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing. 

F-33

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

     Crinetics Pharmaceuticals, Inc.

    Date: February 27, 2025
     
    By:
    /s/ R. Scott Struthers, Ph.D.

    R. Scott Struthers, Ph.D.

    President and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

    Name
     
    Title
     
    Date

    /s/ R. Scott Struthers, Ph.D.
     
    President, Chief Executive Officer and Director
     
    February 27, 2025